Health care system opportunities for engaging women in alcohol use disorder treatment
Active Grant Awarded
- Award ID
- R01AA033065
- Recipient
-
The Johns Hopkins University UEI FTMTDMBR29C7
- Awarding agency
-
National Institute on Alcohol Abuse and Alcoholism
National Institutes of Health, Department of Health and Human Services
- Obligated
- $766,320
Award facts
- Assistance listing
- 93.273 Alcohol Research Programs
- Completion date 6% complete
- Place of performance
- Baltimore, MD 21218, USA
Award details come from USAspending.gov.
About this award
The Department of Health and Human Services, National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism awarded The Johns Hopkins University $766,320 on August 10, 2026, under the Alcohol Research Programs (CFDA 93.273) grant R01AA033065. The award runs through an ultimate completion date of May 31, 2031, with place of performance in Baltimore, Maryland 21218.
The project studies where women with alcohol use disorder (AUD) are initially diagnosed in the health care system and which AUD treatments they subsequently receive, to identify missed opportunities for earlier intervention. The work assembles 2016-2029 Medicare, Medicaid, and commercial insurance claims, which together cover approximately half (49%) of U.S. adults, and applies modern statistical methods to characterize the setting of initial AUD diagnosis among women and the patient factors associated with variation in that setting.
President and Fellows of Harvard College, operating through Harvard Medical School's Office of Research Administration, received a sub-award dated October 22, 2026 (R01AA033065-2007481730). The subrecipient is responsible for analyses of Medicare and Medicaid data and for determining the statistical modeling approach, under the direction of co-investigator Sharon-Lise Normand. Multi-PI Haiden Huskamp co-leads the study with Alene Kennedy-Hendricks at Johns Hopkins.
Description
- Abstract
- Little is known about where women with alcohol use disorder (AUD) are initially identified in the health care system, and whether the circumstances of this initial diagnosis may reveal missed opportunities for earlier intervention or are associated with subsequent treatment patterns and AUD-related outcomes. This is significant given increases in rates of heavy drinking, alcohol use disorder (AUD), and alcohol-related medical complications among women in recent years, narrowing a long-standing GAP in AUD prevalence as well as alcohol-related morbidity and mortality compared with men. Timely access to efficacious, high-quality AUD treatment and recovery support can mitigate the health consequences of heavy alcohol consumption among women. However, few women with AUD report treatment use, and treatment is often delayed from AUD onset. Given rising rates of AUD-related harms among women, improving early AUD identification and treatment engagement in this population is an urgent public health priority. Most extant research on AUD treatment in women is more than a decade old, impeding efforts to respond to the escalating crisis in this population. A comprehensive understanding of where women are diagnosed and, if diagnosed, which AUD treatments they receive, will identify missed opportunities within health care settings. This can, in turn, inform the development of targeted health system and policy reforms to identify AUD and intervene earlier. To fill the research gaps, we will assemble several diverse data sources, including 2016-2029 medicare, medicaid, and commercial insurance claims that together cover approximately half (49%) of all U.S. Adults, and apply modern statistical approaches to: (1) characterize the setting of initial AUD diagnosis in the health care system among women and identify patient factors associated with variation in setting of initial diagnosis; (2) identify women's health system interactions prior to initial AUD diagnosis; and (3A) examine the association between setting of initial diagnosis and time to initiation of treatment and (3B) identify factors associated with AUD treatment patterns and assess the relationship between these patterns and subsequent outcomes. Rigorous statistical approaches include bayesian additive regression trees, latent class modeling, competing risk analyses, and longitudinal targeted minimum loss-based estimation. Across all aims, we will compare age cohorts (18-44, 45- 64, and 65+) to capture how these relationships vary across life stages and assess differences across insurance segments. Findings will directly inform intervention design, clinical practice, insurance coverage, and public policy aimed at improving access to and engagement in AUD treatment for women.
Subawards
| Subrecipient | Amount | Awarded |
|---|---|---|
| President And Fellows Of Harvard College | $416,839 |
Quick answers
Who received award R01AA033065?
R01AA033065 was awarded to The Johns Hopkins University by National Institute on Alcohol Abuse and Alcoholism (National Institutes of Health) on August 10, 2026.
How much is award R01AA033065 worth?
$766,320 has been obligated on R01AA033065.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award